Our previous study demonstrated that hepatic STAMP2 mediates recombinant FGF21-induced improvements in hepatic iron overload in nonalcoholic fatty liver disease through the upregulation of expression of the iron exporter, ferroportin [26]. Here, STEAP4 is linked to metabolic dysfunction-associated steatotic liver disease.